Recent Quarter Total Invested
$7.13 B
Recent Quarter Institutional Ownership Percentage
114.72%
Total Invested of Last Quarter
$7.35 B
Ownership Percentage of Last Quarter
132.84%
Cytokinetics, Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 15.25 M | $805.35 M | 100.00% | 12.96% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 9.69 M | $511.63 M | 19.06% | 8.23% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 7.77 M | $410.52 M | 3.53% | 6.61% |
| STATE STREET CORP | 11/14/2024 | 6.46 M | $341.00 M | -1.38% | 5.49% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 4.83 M | $254.99 M | 10.24% | 4.10% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 3.16 M | $167.11 M | 34.20% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.85 M | $150.43 M | 4.01% | 2.42% |
| RTW INVESTMENTS, LP | 11/14/2024 | 2.72 M | $143.68 M | 0.00% | 2.31% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 2.34 M | $123.44 M | -4.76% | 1.99% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 2.20 M | $116.16 M | 120.00% | 1.87% |
| BOXER CAPITAL, LLC | 11/14/2024 | 2.10 M | $110.88 M | 0.00% | 1.78% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 2.09 M | $110.23 M | 18.12% | 1.77% |
| ARMISTICE CAPITAL, LLC | 11/14/2024 | 1.90 M | $100.14 M | -8.20% | 1.61% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.87 M | $98.93 M | 11.65% | 1.59% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 1.76 M | $92.78 M | 0.00% | 1.49% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 1.66 M | $87.70 M | -11.61% | 1.41% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.50 M | $79.20 M | -27.71% | 1.27% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.32 M | $69.77 M | 42.75% | 1.12% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.23 M | $65.20 M | 11.06% | 1.05% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 11/12/2024 | 1.21 M | $64.04 M | 38.85% | 1.03% |
| MELQART ASSET MANAGEMENT (UK) LTD | 11/14/2024 | 1.21 M | $64.01 M | -27.66% | 1.03% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.18 M | $62.56 M | 4.10% | 1.01% |
| MORGAN STANLEY | 11/14/2024 | 1.17 M | $61.69 M | 5.67% | 0.99% |
| BROWN ADVISORY INC | 11/13/2024 | 1.17 M | $61.56 M | 52.91% | 0.99% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 1.14 M | $60.40 M | 17.16% | 0.97% |
| SARISSA CAPITAL MANAGEMENT LP | 11/14/2024 | 1.11 M | $58.61 B | 0.00% | 0.94% |
| PENTWATER CAPITAL MANAGEMENT LP | 11/14/2024 | 1.10 M | $58.08 M | -1.70% | 0.93% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 990,796 | $52.31 M | 34.32% | 0.84% |
| RP MANAGEMENT, LLC | 11/13/2024 | 980,392 | $51.76 M | 0.00% | 0.83% |
| CITADEL ADVISORS LLC | 11/14/2024 | 937,191 | $49.48 M | 9.11% | 0.80% |
| PENTWATER CAPITAL MANAGEMENT LP | 11/14/2024 | 920,900 | $48.62 M | 0.00% | 0.78% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 911,182 | $48.11 M | 6.71% | 0.77% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 907,295 | $47.91 M | -15.09% | 0.77% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 766,906 | $40.49 M | -5.66% | 0.65% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2024 | 750,000 | $39.60 M | -25.00% | 0.64% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 629,906 | $33.26 M | 375.42% | 0.54% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 561,018 | $29.36 M | 55.58% | 0.48% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 542,284 | $28.63 M | 1.45% | 0.46% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 542,135 | $28.62 M | 57.54% | 0.46% |
| FRANKLIN RESOURCES INC | 11/12/2024 | 536,447 | $29.24 M | 32.93% | 0.46% |
| SIREN, L.L.C. | 11/13/2024 | 525,971 | $27.77 B | 100.00% | 0.45% |
| INVESCO LTD. | 11/12/2024 | 503,091 | $26.56 M | 1.55% | 0.43% |
| CHECKPOINT CAPITAL L.P. | 11/14/2024 | 466,813 | $24.65 M | 145.69% | 0.40% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 464,010 | $24.50 M | 23.79% | 0.39% |
| ENSIGN PEAK ADVISORS, INC | 11/14/2024 | 461,836 | $24.38 M | -0.34% | 0.39% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 400,000 | $21.12 M | 100.00% | 0.34% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 398,100 | $21.02 M | 0.00% | 0.34% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 383,176 | $20.23 M | 7.89% | 0.33% |
| RHUMBLINE ADVISERS | 11/12/2024 | 378,676 | $19.99 M | -0.15% | 0.32% |
| BARCLAYS PLC | 11/19/2024 | 376,996 | $19.91 M | 33.51% | 0.32% |
Cytokinetics, Incorporatedinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CYTK shares?
During the previous two years, 434 institutional investors and hedge funds held shares of Cytokinetics, Incorporated. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 15.25 M
T. Rowe Price Investment Management, Inc.: 9.69 M
WELLINGTON MANAGEMENT GROUP LLP: 7.77 M
STATE STREET CORP: 6.46 M
BANK OF AMERICA CORP /DE/: 4.83 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.16 M
-
What percentage of Cytokinetics, Incorporated stock is owned by institutional investors?
114.72% of Cytokinetics, Incorporated stock is owned by institutional investors.
-
How much institutional buying is happening at CYTK ?
Institutional investors have bought a total of 135.44 M shares in the last 24 months. This purchase volume represents approximately $6.65 B in transactions.